106 participants
A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-10
- Start Date:
- 2022-08-15
- Completion:
- 2025-11-19
Conditions
- Alzheimer's Disease (AD)
Interventions
- DRUG
No Results Yet